drugset
drugset / Trial / NCT02626494

Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction

NCT02626494 ↗

Phase 4 Completed 71 enrolled Psychiatric University Hospital, Zurich Max-Planck-Institut Tübingen · collabSwiss Federal Institute of Technology · collabZurich Center for Integrative Human Physiology · collab
RandomizedCrossoverTriple-blindBasic science

Summary

This study aims at testing for the impact of glutamatergic changes on drug craving in cocaine addiction, and to evaluate the effects of n-acetylcysteine (n-AC) on both glutamate homeostasis and craving using a randomized, double-blind, placebo controlled cross-over design.

Timeline

Start
2015-03
Primary completion
2017-03
Completion
2017-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcystein Unknown 2400 mg —

Indications

cocaine dependence